219 related articles for article (PubMed ID: 27658315)
1. Clinical Trials Registration and Results Information Submission. Final rule.
National Institutes of Health, Department of Health and Human Services
Fed Regist; 2016 Sep; 81(183):64981-5157. PubMed ID: 27658315
[TBL] [Abstract][Full Text] [Related]
2. Informed consent elements. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2011 Jan; 76(2):256-70. PubMed ID: 21261126
[TBL] [Abstract][Full Text] [Related]
3. The web of clinical trial registration obligations: have foreign clinical trials been caught?
Hathaway CR; Manthei JR; Haas JB; Meltzer ED
Food Drug Law J; 2009; 64(2):261-75. PubMed ID: 19999283
[TBL] [Abstract][Full Text] [Related]
4. The proposed rule for U.S. clinical trial registration and results submission.
Zarin DA; Tse T; Sheehan J
N Engl J Med; 2015 Jan; 372(2):174-80. PubMed ID: 25539444
[No Abstract] [Full Text] [Related]
5. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
[TBL] [Abstract][Full Text] [Related]
6. Encouraging research and development of pediatric medical devices through legislative and regulatory action: the Pediatric Medical Device Safety and Improvement Act of 2007 in context.
Bleicher EW
Food Drug Law J; 2009; 64(3):531-64. PubMed ID: 19999642
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials registries: towards improved access to therapeutic data.
Prescrire Int; 2008 Dec; 17(98):256-9. PubMed ID: 19425275
[TBL] [Abstract][Full Text] [Related]
8. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.
DeVito NJ; Bacon S; Goldacre B
Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402
[TBL] [Abstract][Full Text] [Related]
9. Medical devices; investigational device exemptions--FDA. Final rule.
Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
[TBL] [Abstract][Full Text] [Related]
10. FDA given new powers over data reporting to national clinical trials registry.
Roehr B
BMJ; 2012 Oct; 345():e6629. PubMed ID: 23033375
[No Abstract] [Full Text] [Related]
11. Compliance with results reporting at ClinicalTrials.gov.
Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
[TBL] [Abstract][Full Text] [Related]
12. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
[TBL] [Abstract][Full Text] [Related]
13. Medical devices; investigational device exemptions--FDA. Proposed rule.
Fed Regist; 1998 Jul; 63(135):38131-8. PubMed ID: 10181246
[TBL] [Abstract][Full Text] [Related]
14. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study.
Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS
Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601
[TBL] [Abstract][Full Text] [Related]
15. Overcoming non-compliance with clinical trial registration and results reporting: One Institution's approach.
Snider SH; Flume PA; Gentilin SL; Lesch WA; Sampson RR; Sonne SC
Contemp Clin Trials Commun; 2020 Jun; 18():100557. PubMed ID: 32258818
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
Miller JE; Korn D; Ross JS
BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States.
Lassman SM; Shopshear OM; Jazic I; Ulrich J; Francer J
BMJ Open; 2017 Sep; 7(9):e015110. PubMed ID: 28942418
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
19. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
[TBL] [Abstract][Full Text] [Related]
20. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors.
Hirsch L
Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]